Winship realigns its research programs to increase impact

Georgia's Online Cancer Information Center

Winship realigns its research programs to increase impact

1/06/2020, The Cancer Letter

Winship Cancer Institute of Emory University has been granted formal approval from NCI to realign the four research programs funded by its NCI Cancer Center Support Grant. The realignment creates a new Cancer Immunology Research Program, which builds on Winship’s growing strengths in cancer immunology and the integration of immunology research ef forts across Emory University. “This realignment will open up more collaborative possibilities for our faculty and focus our ef forts on research that advances cancer discoveries,” said Kimberly F. Kerstann, Winship senior director for research administration. Madhav Dhodapkar, who joined in 2018 as inaugural director of the Winship Center for Cancer Immunology, and Rafi Ahmed, director of the Emory Vaccine Center, will lead this new program. The program will include translational physicians and scientists at Winship as well as from the Emory Vaccine Center and the Department of Immunology and Microbiology. The realignment also creates another entity, the Cell and Molecular Biology Research Program, led by Jing Chen, and Wei Zhou. The research themes for the CMB program are cancer cell metabolism, cancer cell stress and survival, mechanisms of invasion and metastasis, and gene regulation. Members of the former Cancer Cell Biology and Cancer Genetics and Epigenetics programs will migrate to the new CI and CMB programs. The other two Winship research programs will continue under the same names: Discovery and Developmental Therapeutics Research Program, led by Haian Fu, and Taofeek Owonikoko; and the Cancer Prevention and Control Research Program, led by Timothy L. Lash, and Mylin Torres. The benefit to patients will be significant because these research programs go to the core of how scientific discovery advances the prevention, detection, and treatment of cancer.

Media, News & Events

Georgia Cancer Trial Finders Provider Engagement Webinar

Join us for a 35-minute Georgia Cancer Trial Finders Provider Engagement Webinar on March 26 from 12:15–12:50 PM (ET) featuring Dr. Trevor Feinstein, Chief Medical Officer of Georgia CORE, and Dr. Crain Garrott, Past President of the Georgia Society of Clinical Oncology (GASCO).

Because many referrals to Georgia Cancer Trial Finders originate from clinical teams, increasing provider awareness of this res

3/13/2026

 Clinical Trials, Doctors & Cancer Centers

Hearts Aligned Integrative Educational Conference

This gathering is more than a conference. It is a coming together of medical professionals, integrative practitioners, community leaders, sponsors, and advocates who believe cancer care should include the whole person — body, mind, and spirit. Together, we are creating space for education, empowerment, and expanded access to integrative services for cancer patients, survivors, and caregivers.

3/09/2026

Nominations open for the Cancer Patient Navigation and Cancer Community Service Awards

And for the first time, we are offering an incentive for nominations!

3/05/2026

Strange seats bring colon cancer awareness to Georgia bars, coffee shops

The AJC covers Georgia CORE's unique colon cancer awareness campaign, Weird Looking Stools, helping to raise awareness to look for the signs and symptoms of colon cancer.

10/21/2025

Georgia Cancer Trial Finders Provider Engagement Webinar

Join us for a 35-minute Georgia Cancer Trial Finders Provider Engagement Webinar on March 26 from 12:15–12:50 PM (ET) featuring Dr. Trevor Feinstein, Chief Medical Officer of Georgia CORE, and Dr. Crain Garrott, Past President of the Georgia Society of Clinical Oncology (GASCO).

Because many referrals to Georgia Cancer Trial Finders originate from clinical teams, increasing provider awareness of this res

3/13/2026

 Clinical Trials, Doctors & Cancer Centers

Subscribe to Our Newsletter

Our email newsletter allows you to get the most up-to-date information right in your Inbox.

Subscribe Now